| 1 |
Nakai S, Masakane I, Akiba T, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2005) [J]. Ther Apher Dial,2007,11(6):411-441.
|
| 2 |
Agarwal R, Nissenson AR, Batlle D, et al. Prevalence, treatment,and control of hypertension in chronic hemodialysis patients in the United States [J]. Am J Med,2003,115(4):291-297.
|
| 3 |
林静,丁小强,林攀,等. 上海市维持性血液透析患者高血压现状的多中心调查[J]. 中华内科杂志,2010,49(7):563-567.
|
| 4 |
Agarwal R, Satyan S, Alborzi P, et al. Home blood pressure measurements for managing hypertension in hemodialysis patients[J]. Am J Nephrol,2009,30(2):126-134.
|
| 5 |
Van Buren P, Kim C, Toto R, et al. Intradialytic hypertension and the association with interdialytic ambulatory blood pressure[J]. Clin J am Soc Nephrol,2011,6(7):1684-1691.
|
| 6 |
Agarwal R. Managing hypertension using home blood pressure monitoring among haemodialysis patients-a call to action [J].Nephrol Dial Transplant,2010,25(6):1766-1771.
|
| 7 |
Amerling RCG, Dubrow A, Levin NW, et al. Complications during hemodialysis [M] ∥Nissenson A, Gentile D. Clinical Dialysis.Stamford, CT: Appleton & Lange,1995:242-243.
|
| 8 |
Inrig JK, Patel UD, Toto RD, et al. Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the dialysis morbidity and mortality wave 2 study [J]. Am J Kidney Dis, 2009, 54(5):881-890.
|
| 9 |
Park J, Rhee CM, Sim JJ, et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival [J]. Kidney Int,2013,84(4):795-802.
|
| 10 |
Agarwal R, Andersen MJ, Light RP. Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients[J]. Am J Nephrol,2008,28(2):210-217.
|
| 11 |
K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients [J]. Am J Kidney Dis,2005,45(Suppl 3): S1-S153.
|
| 12 |
Heerspink HJ, Ninomiya T, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials [J]. Lancet,2009,373(9668):1009-1015.
|
| 13 |
Agarwal R, Sinha AD.Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis [J]. Hypertension,2009,53(5):860-866.
|
| 14 |
Mazzuchi N, Carbonell E, Fernández-Cean J. Importance of blood pressure control in hemodialysis patient survival [J]. Kidney Int,2000,58(5):2147-2154.
|
| 15 |
Lynn KL, McGregor DO, Moesbergen T, et al. Hypertension as a determinant of survival for patients treated with home dialysis [J].Kidney Int,2002,62(6):2281-2287.
|
| 16 |
Lacson EJ, Lazarus JM. The association between blood pressure and mortality in ESRD-not different from the general population [J]?Semin Dial,2007,20(6):510-517.
|
| 17 |
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for management of high blood pressure in adults [J].JAMA,2014,311(5):507-520.
|
| 18 |
Inrig JK, Patel UD, Gillespie BS, et al. Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients [J]. Am J Kidney Dis, 2007, 50(1):108-118.
|
| 19 |
Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients [ J ]. Nephrol Dial Transplant,2009,24(5):1574-1579.
|
| 20 |
Agarwal R, Alborzi P, Satyan S, et al. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized,controlled trial [J]. Hypertension,2009,53(3):500-507.
|
| 21 |
Charra B. Fluid balance, dry weight, and blood pressure in dialysis[J]. Hemodial Int,2007,11(1):21-31.
|
| 22 |
Özkahya M, Töz H, Unsal A, et al. Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor [J]. Am J Kidney Dis,1999,34(2):218-221.
|
| 23 |
Agarwal R,Weir MR. Dry-weight:a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients [J]. Clin J Am Soc Nephrol, 2010, 5(7):1255-1260.
|
| 24 |
Kayikcioglu M, Tumuklu M, Ozkahya M, et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis [J]. Nephrol Dial Transplant, 2009, 24 (3):956-962.
|
| 25 |
Tomson CR. Blood pressure and outcome in patients on dialysis[J]. Lancet,2009,373(9668):981-982.
|
| 26 |
Cice G,Ferrara L,D'Andrea A,et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial [J]. J Am Coll Cardiol,2003,41(9):1438-1444.
|
| 27 |
Thai DJ, Lim TW, James MT, et al. Cardiovascular effects of Angiotensin converting enzyme inhibition or Angiotensin receptor blockade in hemodialysis: a meta-analysis [J]. Clin J Am Soc Nephrol,2010,5(4):623-630.
|
| 28 |
Hiromichi Suzuki, Yoshihiko Kanno, Soichi Sugahara, et al. Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial[J]. Am J Kidney Dis,2008,52(3):501-506.
|
| 29 |
Kestenbaum B, Gillen DL, Sherrard DJ, et al. Calcium channel blocker use and mortality among patients with end-stage renal disease[J]. Kidney Int,2002,61(6):2157-2164.
|
| 30 |
Ishani A, Herzog CA, Collins AJ, et al. Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect [J]? Kidney Int, 2004, 65(3): 1017-1025.
|
| 31 |
Tepel M, Hopfenmueller W, Scholze A, et al. Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients [J].Nephrol Dial Transplant,2008,23(11):3605-3612.
|